The Therapeutic Potential of Psilocybin and 3, 4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder

Abstract

The psychedelic psilocybin and the entactogen 3, 4-methylenedioxymethamphetamine (MDMA) are being scientifically studied again after a long hiatus, and especially for their potential in the treatment of psychiatric disorders. Their profound effect on cognitive …